170 related articles for article (PubMed ID: 29991692)
1. Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis.
Vsiansky V; Gumulec J; Raudenska M; Masarik M
Sci Rep; 2018 Jul; 8(1):10370. PubMed ID: 29991692
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
[TBL] [Abstract][Full Text] [Related]
3. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.
Chen Y; Cong R; Ji C; Ruan W
Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589
[TBL] [Abstract][Full Text] [Related]
4. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
5. Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas.
Baschnagel AM; Tonlaar N; Eskandari M; Kumar T; Williams L; Hanna A; Pruetz BL; Wilson GD
J Oral Pathol Med; 2017 Mar; 46(3):208-213. PubMed ID: 27442811
[TBL] [Abstract][Full Text] [Related]
6. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
Zhou LQ; Hu Y; Xiao HJ
BMC Cancer; 2021 Apr; 21(1):424. PubMed ID: 33863308
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review.
Kim JH; Kim BJ; Kim HS
Oncotarget; 2017 Dec; 8(68):113120-113128. PubMed ID: 29348891
[TBL] [Abstract][Full Text] [Related]
10. Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis.
Zhu Y; Liu H; Xie N; Liu X; Huang H; Wang C; Hou J
Head Neck; 2019 Feb; 41(2):542-550. PubMed ID: 30549142
[TBL] [Abstract][Full Text] [Related]
11. Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).
Liu D; Zhong M; Zhan D; Zhang Y; Liu S
Oncol Rep; 2020 Dec; 44(6):2337-2344. PubMed ID: 33125120
[TBL] [Abstract][Full Text] [Related]
12. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
[TBL] [Abstract][Full Text] [Related]
13. HGF-Induced PD-L1 Expression in Head and Neck Cancer: Preclinical and Clinical Findings.
Boschert V; Teusch J; Aljasem A; Schmucker P; Klenk N; Straub A; Bittrich M; Seher A; Linz C; Müller-Richter UDA; Hartmann S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233528
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
Zhou C; Sun B
Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic value of circRNAs expression in head and neck squamous cell carcinoma: A meta-analysis.
Feng H; Wang D; Liu J; Zou L; Xu S; Liang Z; Qin G
J Clin Lab Anal; 2022 Jul; 36(7):e24496. PubMed ID: 35595945
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
17. Role of c-Met expression on prognosis of head and neck cancer: A literature review and meta-analysis.
Li L; Sun Z; Huang X; Li X; Sun L; Zhang L; Zhang X; Ye L; Yuan J; Mao L; Li G
Head Neck; 2019 Jun; 41(6):1999-2006. PubMed ID: 30708403
[TBL] [Abstract][Full Text] [Related]
18. MET ectodomain shedding is associated with poor disease-free survival of patients diagnosed with oral squamous cell carcinoma.
De Herdt MJ; Koljenović S; van der Steen B; Willems SM; Noorlag R; Nieboer D; Hardillo JA; Gruver AM; Zeng W; Liu L; de Jong RJB; Looijenga LH
Mod Pathol; 2020 Jun; 33(6):1015-1032. PubMed ID: 31857683
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of circulating tumor cells in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Xun Y; Cao Q; Zhang J; Guan B; Wang M
Oral Oncol; 2020 May; 104():104638. PubMed ID: 32182549
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
González-Moles MÁ; Ayén Á; González-Ruiz I; de Porras-Carrique T; González-Ruiz L; Ruiz-Ávila I; Ramos-García P
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
